Informa Connect’s Rare Disease Summit convenes industry, patient groups, investors and policy makers to unite in areas of unmet medical need and create life-transforming therapies and breakthroughs. Connect with key stakeholders and propel curative progress, orphan product success and patient advocacy.
Bethany Hills was a speaker for the "FDA Clinical Process and U.S. Regulatory Submissions" session.
Additional speakers for the session:
Leonide Saad - CEO, Alkeus Pharmaceuticals, Inc.
Mark A. Rutter - Senior Director, Global Regulatory Policy, Biogen